127 related articles for article (PubMed ID: 21420360)
1. 5-HT: the promiscuous and happy hormone!
Barnes NM
Curr Opin Pharmacol; 2011 Feb; 11(1):1-2. PubMed ID: 21420360
[No Abstract] [Full Text] [Related]
2. Targeting 5-HT receptors for the treatment of obesity.
Sargent BJ; Henderson AJ
Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
[TBL] [Abstract][Full Text] [Related]
3. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
4. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
Lefebvre H
Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
[No Abstract] [Full Text] [Related]
5. Effects of serotonin 1A agonist on acute spinal cord injury.
Saruhashi Y; Matsusue Y; Hukuda S
Spinal Cord; 2002 Oct; 40(10):519-23. PubMed ID: 12235534
[TBL] [Abstract][Full Text] [Related]
6. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
7. Preface. Physiological, pathophysiological and therapeutic aspects of 5-HT mechanisms.
Meneses A
Behav Brain Res; 2008 Dec; 195(1):1. PubMed ID: 18706936
[No Abstract] [Full Text] [Related]
8. Serotonin receptor and reuptake sites: pharmacologic significance.
Gonzalez-Heydrich J; Peroutka SJ
J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
[TBL] [Abstract][Full Text] [Related]
9. 5-HT6 pharmacology inconsistencies.
Borsini F; Bordi F; Riccioni T
Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
[TBL] [Abstract][Full Text] [Related]
10. A review of central 5-HT receptors and their function.
Barnes NM; Sharp T
Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine and cardiovascular regulation.
Ramage AG; Villalón CM
Trends Pharmacol Sci; 2008 Sep; 29(9):472-81. PubMed ID: 19086344
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation.
Doggrell SA
Expert Opin Investig Drugs; 2003 May; 12(5):805-23. PubMed ID: 12720492
[TBL] [Abstract][Full Text] [Related]
13. Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences.
Bagdy G
Ann N Y Acad Sci; 1998 Jun; 851():357-63. PubMed ID: 9668626
[No Abstract] [Full Text] [Related]
14. [Serotoninergic receptors: physiological and therapeutic implications].
del Río J; Lasheras B
Rev Med Univ Navarra; 1993; 38(3):29-38. PubMed ID: 8134752
[No Abstract] [Full Text] [Related]
15. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
Wesołowska A; Jastrzębska-Więsek M
Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
[No Abstract] [Full Text] [Related]
16. The serotonin system and alcoholism: basic research and clinical problems.
Gallant D
Alcohol Clin Exp Res; 1993 Dec; 17(6):1345. PubMed ID: 8116852
[No Abstract] [Full Text] [Related]
17. Drugs affecting 5-hydroxytryptamine function.
Drug Ther Bull; 1993 Mar; 31(7):25-7. PubMed ID: 8344147
[No Abstract] [Full Text] [Related]
18. Serotonergic mechanisms and current and future psychiatric practice.
Dubovsky SL; Thomas M
J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106
[TBL] [Abstract][Full Text] [Related]
19. The importance of 5-hydroxytryptamine receptors in the gut.
Read NW; Gwee KA
Pharmacol Ther; 1994; 62(1-2):159-73. PubMed ID: 7991641
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of serotonin: what a clinician should know.
De Ponti F
Gut; 2004 Oct; 53(10):1520-35. PubMed ID: 15361507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
